Alex Norris MP

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the level of patient involvement in the NICE process for evaluating and approving new medicines and treatment; and whether there are plans under the o...

To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of people with undiagnosed liver disease.

To ask the Secretary of State for Health and Social Care, what comparative assessment his Department has made of the number of deaths due to liver disease and other major diseases; and if he will make a statement.

To ask the Secretary of State for Health and Social Care, what data his Department holds on the number of patients diagnosed with (a) liver disease, (b) alcohol-related liver disease and (c) non-alcoholic fatty liver disease in each local authority area i...

To ask the Secretary of State for Health and Social Care, what steps he has taken to progress the Government’s commitment to expanding NHS weight management services in England in the July 2020 obesity strategy; and if he will make a statement.

To ask the Secretary of State for Health and Social Care, when weight management services will be delivered in more locations; and if he will make a statement.

To ask the Secretary of State for Health and Social Care, with reference to the Spending Review 2020 and OBR Forecast statement on 25 November 2020, what plans the Government has to provide funding to expand access to weight management services; and if he...

To ask the Secretary of State for Health and Social Care, when the Government will announce further details of its water fluoridation plans.

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that covid-19 vaccines are accessible for people with mental health issues.

To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to ensure that all (a) homecare workers working for (i) registered and (ii) unregistered organisations, (b) live-in carers and (c) personal assistant care w...

To ask the Secretary of State for Business, Energy and Industrial Strategy, what guidance he plans to publish to raise awareness that essential businesses affected by covid-19 restrictions are eligible for the lockdown discretionary grant fund announced o...

To ask the Secretary of State for Health and Social Care, what assessment he has made of the viability of allowing changes to childcare bubbles at shorter notice than the expiry of the minimum period in emergency situations.

To ask the Secretary of State for Health and Social Care, whether the Government plans to adapt the roll-out of the covid-19 vaccine programme to allow more local communities to receive the vaccine from their community pharmacy.

To ask the Secretary of State for Justice, what assessment he has made of the effect of the transfer of multi-hander trials on the length delays to outstanding cases in regions where those multi-hander trials were transferred to.

To ask the Secretary of State for Justice, how many multi-hander trials were moved to another court in 2020; and which courts those trials were moved to and from.

To ask the Secretary of State for Justice, what assessment he has made of trends in the level of defendants offending while awaiting delayed court dates.

To ask the Secretary of State for Education, what steps his Department is taking to support the school catering industry during the covid-19 outbreak.

To ask the Secretary of State for Health and Social Care, what the take-up of winter flu vaccinations was in (a) 2018, (b) 2019 and (c) 2020 to date.

To ask the Secretary of State for Health and Social Care, pursuant to Answer of 9 October 2020 to Questions 91703 and 91704 on Influenza: Vaccination, how many additional trained workforce personnel are being made available to local providers (a) across E...

To ask the Secretary of State for Justice, what plans he has to increase sitting days for Judges in Crown Courts in regions with high numbers of outstanding trials.